Betacellulin drives therapy resistance in glioblastoma.

Saved in:
Bibliographic Details
Title: Betacellulin drives therapy resistance in glioblastoma.
Authors: Fan Q; Department of Neurology, University of California San Francisco (UCSF), San Francisco, California.; Helen Diller Family Comprehensive Cancer Center, San Francisco, California., An Z; Department of Neurology, University of California San Francisco (UCSF), San Francisco, California.; Helen Diller Family Comprehensive Cancer Center, San Francisco, California., Wong RA; Department of Neurology, University of California San Francisco (UCSF), San Francisco, California.; Helen Diller Family Comprehensive Cancer Center, San Francisco, California., Luo X; Department of Neurology, University of California San Francisco (UCSF), San Francisco, California.; Helen Diller Family Comprehensive Cancer Center, San Francisco, California., Lu ED; Department of Neurology, University of California San Francisco (UCSF), San Francisco, California.; Helen Diller Family Comprehensive Cancer Center, San Francisco, California., Baldwin A; Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina., Mayekar MK; Helen Diller Family Comprehensive Cancer Center, San Francisco, California., Haderk F; Helen Diller Family Comprehensive Cancer Center, San Francisco, California., Shokat KM; Howard Hughes Medical Institute and Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, California., Bivona TG; Helen Diller Family Comprehensive Cancer Center, San Francisco, California., Weiss WA; Department of Neurology, University of California San Francisco (UCSF), San Francisco, California.; Helen Diller Family Comprehensive Cancer Center, San Francisco, California.; Department of Pediatrics, University of California San Francisco, San Francisco, California.; Department of Neurological Surgery, University of California San Francisco, San Francisco, California.
Source: Neuro-oncology [Neuro Oncol] 2020 Apr 15; Vol. 22 (4), pp. 457-469.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1523-5866
DOI:10.1093/neuonc/noz206